PIH38 The Relative Influence of Perceived Need for Medications Versus Perceived Medication Concerns in Determining Medication Adherence: Narrative Systematic Review and Meta-Analysis  by Zhang, N.J. & McHorney, C.
coverage gap period, a considerable proportion of beneficiaries stopped taking
medications in both the groups and the proportion of beneficiaries considered
adherent (MPR0.80) also dropped for both the groups. CONCLUSIONS: Medicare
Part D beneficiaries face significant barriers to adherence, especially those reaching
the coverage gap. Interventions to improve adherence should target all beneficia-
ries, particularly those using multiple medications.
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OBJECTIVES: To establish any impact of the high deductible Consumer Directed
Health Plans (CDHP) on the overall utilization and adherence outcomes for some
key therapeutic classes one year post implementation.METHODS: CVS Caremark
pharmacy claims data (7/1/2008 – 7/1/2011) was analyzed. This study was designed
as a retrospective pre-post cohort study. For the clients who implemented CDHP in
2010, we compared overall utilization and adherence (pre- and post- implementa-
tion date) between patients who opted into CDHP vs. those who stayed in Tradi-
tional (non-CDHP) plans for specific therapies: angiotensin-converting enzyme in-
hibitors (ACEIs) or angiotensin-II receptor blockers (ARBs), HMG-CoA reductase
inhibitors (statins), and Biguanides (e.g. metformin), identified based on the GPI-4
and GPI-6 codes (Biguanides: 2725/279970/279980- ARBs: 3615/369930/369940-
ACEIs: 3610/369930/369940- STATINS: 3940- PPIs: 4927). Bi-variate and multi-vari-
ate analyses, including mixed effects, were conducted using SAS Version 9.1 (9.2)
with SAS/STAT. RESULTS: The total of 132,846 patients met inclusion criteria. Ge-
neric Dispense Rate (GDR) increased by 5.9% (p0.001) in the CDHP cohort com-
pared to the 4.7% (p0.001) increase in the Traditional cohort between the pre and
post periods. No significant differences were observed in the 90-day supply distri-
bution between the two cohorts. Observed (unadjusted) 12-months adherence did
not change significantly post CDHP implementation in the 4 key therapeutic class-
es: STATINS, ACEIs, ARBs, and BIGUANIDES. The utilization of PPIs decreased post-
implementation by 0.34% (p0.05) in the CDHP cohort, while it increased by 2.5%
(p0.001) in the Traditional cohort. CONCLUSIONS: CDHPmembers were observed
to behave in a cost-effective manner. Post-implementation increase in GDR in the
CDHP cohort was 1.2% (p0.001) higher compared with the members in the Tradi-
tional cohort. The CDHP cohort demonstrated decreased utilization of some non-
essential medications, but their observed adherence to key therapies was unaf-
fected.
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OBJECTIVES: Patient-centered care is seen as a critical factor in a high-perfor-
mance health care system. We considered a randomized decision-situation in
which the available information is given by three hypothetical health states (infor-
mation sets: consider youhave beendiagnosedwith diabetes, lung cancer, or based
on the status quo of the respondent).METHODS:Within a discrete-choice experi-
ment (DCE) 21 characteristics of a healthcare delivery system are being used to
construct 4 DCEs based on thematic mapping (patient-involvement; point of care;
personnel; organization). Each DCE included six attributes with three specific lev-
els. Furthermore respondents were randomly assigned and asked to make their
decisions based on different information sets. RESULTS: For the N3900 respon-
dents the feature “out-of-pocket costs” was the important attribute across all 4
DCEs (DCE-1 coefficient, 0,6550; DCE-2 coefficient, 0,8624; DCE-3 coefficient, 0,6991;
DCE-4 coefficient, 0,7926). Only “multidisciplinary care” in DCE-3 (Personnel)
scored higher than cost with a coefficient of 0,7081. In DCE1 regarding patient-
involvement, “trust and respect” (0,6187) and in DCE 2 addressing preferences at
the point of care, “shared-decisionmaking” (0,7125)were of greatest importance. In
DCE 4 the attribute “treatment guidelines” (0,4682) was of high importance. The
analysis showed that the relevance of the “out-of-pocket cost” changed when re-
spondentswere asked to consider their responses in the context of diabetes or lung
cancer diagnosis (status quo: 0.6749; diabetes: 0.81145; lung cancer: 0.50431). Fur-
thermore, the feature “trust and respect” (status quo: 0.70338; diabetes: 0.65555;
lung cancer: 0.6369) was also less valuable when participants assumed a worse
health state. CONCLUSIONS: The study aimed to close the gap between simplistic
representations of patient preferences in today’s health care systems and the com-
plexity of actual patient decision-making processes by using the explanatory
power of DCEs. Understanding how patients and stakeholders perceive and value
different aspects of coordinated care is vital to the optimal design and evaluation of
programs.
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OBJECTIVES:This study aims to: identify patient preferences for prescription-med-
ication information in terms of temporal framing (short- vs. long-term outcomes)
and examine factors associated with such information preferences. METHODS: A
total of 12,689 surveys were obtained from the Harris Interactive Chronic Illness
Panel, a nationally-representative, Internet-based panel of adults with chronic dis-
ease. Respondents were asked to rank order their preferences for prescription-
medication information in terms of information that underscored short- versus
long-term health outcomes. Logistic regression was used to examine factors asso-
ciated with first-declared preference for temporal framing. Independent variables
were demographics and multi-item scales assessing medication beliefs (perceived
necessity, perceived concerns, perceived affordability, patient knowledge) and
present orientation as measured by the Concern for Future Consequences scale.
RESULTS: Average age was 60 (range of 40-92), 52% were female, and 92% were
Caucasian. A full 84% of respondents preferred prescription-medication informa-
tion about long-term health outcomes. Preferences for long-term outcome infor-
mation were significantly associated (p  0.01) in multivariate models with older
age, higher income, having drug-insurance benefits, higher perceived affordability,
higher perceived necessity, and lower present-time orientation. For example, per-
sons with high perceived medication affordability were 1.9 times more likely to
prefer information about long-term health outcomes compared to those with low
perceived affordability. Persons with high perceived need for medications were 1.6
times more likely to prefer information about long-term health outcomes com-
pared to thosewith lowperceived need. Personswith lowpresent orientation twice
as likely to prefer information about long-termhealth outcomes compared to those
high in present orientation. CONCLUSIONS: Information about the long-term ef-
fects of prescriptionmedicationswas themost preferred information expressed by
12,689 adults with chronic disease and was influenced significantly by medication
beliefs and present orientation. Providers, manufactures, and payers should ac-
knowledge these temporal preferences when developing patient-education mate-
rials about prescription medications.
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OBJECTIVES: The Beliefs about Medication Questionnaire (BMQ) is a measure of
patients’ medication beliefs (perceived need for medications and perceived medi-
cation concerns), and it has been used widely in investigations of medication ad-
herence. To date, there has been little assessment of the relative importance of
necessity vs. concerns in determining medication adherence. Using a systematic
literature review and subsequentmeta-analysis, this study evaluates the impact of
BMQ necessity, concerns, and necessity-concerns differential as a predictor of
medication adherence.METHODS: Articles were identified through searches con-
ducted on MEDLINE, CINAHL, Psych Info, EMBASE, International Pharmaceutical
Abstracts, PubMed, and review of reference citations. Methodological variables,
effect sizes of associations, diseases, and measures of adherence were abstracted
from each eligible article. Studies were categorized by BMQ measures (necessity,
concerns, and the differential), statistical significance (bivariate or multivariate
significance, insignificance, or not applied), disease category, and adherence-out-
come metric. The relative impact of BMQ measures on adherence across different
categories was assessed. RESULTS: Across 77 studies, significant multivariate as-
sociations were reported between adherence and perceived concerns (57.4%), per-
ceived necessity (75.6%), and the differential (88.9%). Two-thirds of the 33 multi-
variate analyses demonstrated higher effect sizes (odds ratios or standardized
regression coefficients) between necessity and adherence than between concern
and adherence. There was wide variation between BMQ measures and adherence
across diseases and adherence metrics. For example, necessity was significantly
associated with adherence in 100% of diabetes studies but 0% of renal studies.
Self-reported adherence metrics and pill counts had the lowest and highest rates,
respectively, of statistical significance with BMQ. CONCLUSIONS: Perceived need
formedications is amore potent predictor of adherence thanmedication concerns.
Perceived need formedication is amutable patient belief. Adherence interventions
may improve their effectiveness if perceived need for medications became a cen-
tral theoretical and interventional focus.
PIH39
ELICITING PREFERENCES TO THE EQ-5D-5L HEALTH STATES: DISCRETE CHOICE
EXPERIMENT OR MULTIPROFILE CASE OF BEST-WORST SCALING
Xie F1, Pullenayegum E1, Gaebel K1, Oppe M2, Krabbe PFM3
1McMaster University, Hamilton, ON, Canada, 2iMTA, Rotterdam, The Netherlands, 3University
of Groningen, Groningen, The Netherlands
OBJECTIVES: To compare the feasibility and reliability of the binary discrete choice
experiment (DCE) and themultiprofile case of best-worst scaling (BWS) techniques
in eliciting preferences for the EQ-5D-5L. METHODS: Forty-eight EQ-5D-5L health
states (HS) were selected using a Bayesian efficient design and grouped into 24
pairs for DCE tasks and eight sets for BWS tasks (each set has threeHS). Participants
completed 12 pairs and eight sets in randomorder. Time to complete each taskwas
recorded. Participants were asked to rank each HS using a visual analogue scale
(VAS). Each participant completed, for a second time, 3 DCE pairs and 2 sets of the
BWS tasks randomly selected from the original pairs and sets, respectively. Partic-
ipants answered questions about the difficulty in imagining EQ-5D-5L HS and in
completing the tasks. A conditional probit model was used to estimate latent util-
ities for the EQ-5D-5L HS which were subsequently rescaled to facilitate the
comparison. RESULTS:One hundred persons participated (mean age: 45 years, 66%
female, 75% well-educated). Mean time to complete 12 DCE tasks was 7.7 minutes
and 10.1 minutes for eight BWS tasks. Some level of difficulty imagining the EQ-
5D-5LHSwas reported by 70%of participants. Only 13%of the participants reported
no difficulty when choosing between two HS or from three HS. The intraclass
correlation coefficient (ICC) was 0.53 for DCE tasks and 0.45 for BWS tasks. The
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